U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The New York TimesWednesday, November 26, 2025 at 1:08:45 AM
PositiveHealth
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
  • The Trump administration announced negotiated prices for 15 drugs under Medicare, which, if implemented last year, could have saved Medicare $12 billion, reducing spending on these medications by 44 percent. The list includes commonly used inhalers like Breo Ellipta, as well as treatments for cancer, diabetes, and depression.
  • This development is significant as it highlights efforts to lower prescription drug costs for Medicare beneficiaries, potentially improving access to essential medications and alleviating financial burdens on the healthcare system.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices
PositiveHealth
The U.S. government has negotiated lower prices for Ozempic and 14 other popular prescription drugs, resulting in significant cost reductions for Medicare. This initiative is expected to save Medicare billions in prescription-drug spending, enhancing affordability for beneficiaries.
New limits on school loans could narrow physician and nurse pipeline, educators warn
NegativeHealth
The Trump administration has implemented new rules limiting the amount students can borrow for medical and nursing schools, potentially reducing the number of future physicians and nurses. This change is part of a broader strategy to reshape federal education policy, which has faced significant criticism.